Lv4
446 积分 2025-03-27 加入
Defining estimands for efficacy assessment in single arm phase 1b or phase 2 clinical trials in oncology early development
1天前
已完结
Application of estimand framework in ICH E9 (R1) to safety evaluation
1天前
已完结
Principles for Defining Estimands in Clinical Trials—A Proposal
1天前
已完结
What is the research question? Estimands explained
1天前
求助中
Enhancement of Bayesian optimal interval design by accounting for overdose and underdose errors trade-offs
5天前
已完结
BOIN-ETC: A Bayesian optimal interval design considering efficacy and toxicity to identify the optimal dose combinations
5天前
已完结
Backfilling Patients in Phase I Dose-Escalation Trials Using Bayesian Optimal Interval Design (BOIN)
6天前
已完结
皖公网安备34019202002308
